| 【Company Research】WuXi Biologics (2269 HK) – Earnings beat driven by strong demand in COVID-19 related projects |
| 【Company Research】Anta Sports (2020 HK) – Guidance maintained but be cautious on opex |
| 【Company Research】Glodon (002410 CH) – Operating leverage from SaaS emerging |
| 【Company Research】Chinasoft (354 HK) – Strong demand but labour cost weighs on margins |
| 【Company Research】Goldwind - H (2208 HK) – 1H21 results beat; accelerating wind farm sales to boost earnings growth |
| 【Company Research】China Lilang (1234 HK) – A transition year but with attractive yield |
| 【Fixed Income Research】ZHPRHK - Better entry opportunities as more differentiation expected |
| 【Fixed Income Research】HONGQI – Reiterate OW on solid fundamental and diversification play |
| 【Sector Research】China CIS market – Beginning of multi-year growth cycle; Initiate BUY on Willsemi and GalaxyCore |
| 【Company Research】Xtep (1368 HK) – Stable 2H21E and upbeat long-term guidance |
Address: 45th & 46th Floor, Champion Tower, 3 Garden Road, Central, Hong Kong
Telephone: （852）3900 0888 Fax:（852）3761 8788
Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
